⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9936989 | 0.80 | ALDH1A1 (0.30) | — | |
| SCHEMBL4432674 | 0.80 | — | — | |
| SCHEMBL9295399 | 0.80 | ALDH1A1 (0.34) | — | |
| SCHEMBL970308 | 0.80 | — | — | |
| SCHEMBL4600069 | 0.80 | ALDH1A1 (0.31) | — | |
| SCHEMBL11194367 | 0.80 | ALDH1A1 (0.30) | — | |
| SCHEMBL6823381 | 0.80 | ACHE (0.31) | — | |
| SCHEMBL4279071 | 0.76 | CASP6 (0.34) | — | |
| SCHEMBL4272720 | 0.76 | VCAM1 (0.33) | — | |
| SCHEMBL15288773 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622280-B2 | Emulsion compositions | 454 LIFE SCIENCES CORPORATION (US) | 2009-11-24 | — | — | US | claimed |
| EP-1518937-B1 | Increasing the concentration of a nucleic acid molecule | MEDICAL RES COUNCIL (GB) | 2007-09-05 | — | — | EP | claimed |
| EP-1518937-A1 | Increasing the concentration of a nucleic acid molecule | MEDICAL RESEARCH COUNCIL (GB) | 2005-03-30 | — | — | EP | claimed |
| US-20050064460-A1 | Emulsion compositions | MEDICAL RESEARCH COUNCIL | 2005-03-24 | — | — | US | claimed |
| EP-1347301-A1 | METHOD FOR ULTRA-RAPID AND ULTRA-SENSITIVE MEASUREMENT | International Reagents Corporation (JP) | 2003-09-24 | — | — | EP | claimed |
| US-5405950-A | N4 -substituted cytidines and process for incorporation into an oligonucleotides | AMOCO CORPORATION (US) | 1995-04-11 | — | — | US | claimed |
| CN-114751920-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-114736219-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| US-20240166666-A1 | ANTITUMORAL COMPOUNDS | PHARMA MAR SA (ES) | 2024-05-23 | — | — | US | disclosed |
| CN-117986153-A | Ionizable cationic lipid compound, and preparation method and application thereof | 晟迪生物医药(苏州)有限公司 | 2024-05-07 | — | — | CN | disclosed |
| EP-3604385-B1 | HETEROBIFUNCTIONAL MONODISPERSED POLYETHYLENE GLYCOL AND CONJUGATE USING THE SAME | NOF CORP (JP) | 2024-05-01 | — | — | EP | disclosed |
| US-20240131180-A1 | DRUG ANTIBODY CONJUGATES | PHARMA MAR, S.A. (ES) | 2024-04-25 | — | — | US | disclosed |
| CN-117865987-A | Antitumor compounds | 法马马有限公司 | 2024-04-12 | — | — | CN | disclosed |
| EP-0222889-A4 | CYTIDINE ANALOGS. | INTEGRATED GENETICS INC (US) | 1988-09-28 | — | — | EP | disclosed |
| US-4676980-A | A HETEROAGGREGATE ABLE TO BIND TO BOTH A CYTOTOXIC CELL AND CELL TO BE LYSED; ANTITUMOR AND CARCINOGENIC AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1987-06-30 | — | — | US | disclosed |
| EP-0222889-A1 | CYTIDINE ANALOGS. | INTEGRATED GENETICS INC (US) | 1987-05-27 | — | — | EP | disclosed |
| EP-0217688-A1 | Peptide derivatives with a lactonic or cycloamidic structure, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1987-04-08 | — | — | EP | disclosed |
| US-4629688-A | CLINICAL ANALYSIS | MILES LABORATORIES, INC. (US) | 1986-12-16 | — | — | US | disclosed |
| WO-1986006726-A1 | CYTIDINE ANALOGS | INTEGRATED GENETICS, INC. (US) | 1986-11-20 | — | — | WO | disclosed |
| US-4383031-A | LIGANDS; IMMUNOASSAY; SIMPLIFICATION; DIAGNOSIS/MEDICAL/ | MILES LABORATORIES, INC. (US) | 1983-05-10 | — | — | US | disclosed |